Filana Therapeutics Will Attend 2026 Maxim Growth Summit
Management from the epilepsy research firm will participate in one-on-one meetings in New York City this October.
Updated on Oct. 10, 2026 in Biotech
Filana Therapeutics, a company developing treatments for Tuberous Sclerosis Complex-related epilepsy, will participate in the 2026 Maxim Growth Summit from October 12-14, 2026. The event will host the Austin-based firm for a series of one-on-one meetings at the Hard Rock Hotel NYC.
Why it matters
The company focuses on therapies for Tuberous Sclerosis Complex, a rare genetic disorder that frequently causes epilepsy. Participation in industry summits serves as a primary mechanism for companies to connect with investors and partners while advancing their clinical pipelines.
The conference format features one-on-one meetings scheduled throughout the three-day window. While the summit provides a venue for institutional exchange, the company's specific clinical performance data remains undisclosed for this event.
The players
Filana Therapeutics
A biotechnology firm based in Austin, Texas, focused on developing therapeutic interventions for Tuberous Sclerosis Complex-related epilepsy.
The details
Filana Therapeutics develops specialized therapies for patients diagnosed with Tuberous Sclerosis Complex, a condition characterized by benign tumors in the brain and other vital organs that often trigger seizures. By engaging in private, one-on-one summit meetings, management can share updates on their development programs with stakeholders. The company operates out of Austin, Texas, working to address the underlying neurological manifestations associated with the complex.
Timeline
October 12-14, 2026: Filana Therapeutics participates in the Maxim Growth Summit.
The Tech Race
The 2026 Maxim Growth Summit serves as a nexus for emerging biotech firms to communicate progress on specialized therapies to the investment community. Filana Therapeutics joins this event as part of a broader cohort of growth-stage companies seeking to advance their neurological clinical programs.
This event provides an opportunity for Filana Therapeutics to secure the resources necessary to continue its research into epilepsy therapies. Local residents in New York City may observe increased industry activity at the Hard Rock Hotel during the three-day conference.
The takeaway
Future updates from Filana Therapeutics will likely focus on their Tuberous Sclerosis Complex treatment pipeline as the company advances through its clinical research phase. Interested parties should monitor subsequent filings and company announcements following the conclusion of the October summit.
What happens next
The summit is scheduled to take place at the Hard Rock Hotel NYC from October 12-14, 2026.
Further reading
For more on the latest developments in the field, explore the Biotech section.
More information
View full details and scheduling information on the Maxim Growth Summit information page.
